Artificial Intelligence | Machine Learning | Machine Perception OneThree Biotech | Redesigning Drug Discovery with Biology-Driven AI


Biotechnology, Drug Discovery, Drug Development, Genetics New York, NY, United States

OneThree Biotech

Artificial Intelligence | Machine Learning | Machine Perception


OneThree Biotech | Redesigning Drug Discovery with Biology-Driven AI

OneThree Biotech

Biotechnology, Drug Discovery, Drug Development, Genetics


New York, NY, United States

OneThree Biotech redesigns drug discovery with biology-driven artificial intelligence to uncover new insights. Its platform predicts new potential therapeutics and pinpoints the mechanisms driving efficacy. It also integrates over 30 types of chemical, biological, and clinical data for each task that leads to a significant increase in accuracy, interpretability, and chance of clinical success. OneThree Biotech is a VC backed startup working to change how new medicines are discovered using biology-driven AI. We all know someone who’s been affected by cancer, and we’ve proven that our technology can help get life-saving treatments to patients faster (people.com/health/teacher-brain-tumor-week-to-live-now-thriving). Having already signed a set of Fortune 500 paying clients, we’re ramping up for our next phase of growth and are looking for a bold and self-motivated engineer to join us as we change healthcare for the better.

 
 

   Total Funding: $2.5 M

   Funding Stage: Seed

   Business Stage: Scaling Up

   Market: B2B

   Company Size: 1 to 25

   Founded: 2018

 
 
 
 
Brad Pryde


Brad Pryde
Co-Founder and Chief Operating Officer

Neel Madhukar


Neel Madhukar
CEO, Co-Founder

Coryandar Gilvary


Coryandar Gilvary
Chief Data Scientist

 
 

OneThree Biotech is growing. Want to work at OneThree Biotech? OneThree Biotech is hiring. Join team at OneThree Biotech

 
 
appengine.ai

World's Most Promising AI/ML Startups